Pharmafile Logo
Pharmafocus logo
Advanced Search

King’s College London

Showing 4 posts of 4 posts found.

800px-blausen_0704_parkinsonsdisease

Scientists at King’s College London identify early signs of Parkinson’s disease

June 20, 2019
Research and Development King's College London, Kings College London, Parkinson's disease, pharma, serotonin

Scientists at King’s College London say they have identified the earliest signs of Parkinson’s disease in the brain – 15 …

News
ritalin-sr-20mg-1000x1000

Darknet sales of prescription psychiatric drugs increasing in the UK

February 27, 2019
Research and Development, Sales and Marketing King's College London, Kings College London, University of Kent, darknet, pharma

Research from the University of Kent and King’s College London has revealed that UK sales of prescription psychiatric drugs, including …

News
800px-t_lymphocyte_16760076824

KCL researchers find link between overactive immune system and Chronic Fatigue Syndrome/ ME

December 20, 2018
Research and Development CFS, KCL, King's College London, Kings College London, ME

Chronic fatigue syndrome (CFS) or Myalgic encephalomyelitis (ME) may be caused by an overactive immune system, according to researchers at …

News
medicinal_cannabis_uk_review

CBD dampens activity in brain regions associated with psychosis, study shows

August 30, 2018
Research and Development CBD, King's College London, Kings College London, Marijuana, psychosis, study

Cannabidiol (CBD), one of the major constituents of cannabis, may be beneficial for patients with psychotic disorders due to its …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025